Most recent by Carsten Rudolph, PhD
SPONSORED CONTENT
December 13, 2023
3 min read
Save
Q&A: Inhaled mRNA therapy may help combat seasonal, emerging respiratory viruses
The U.K. Medicines and Healthcare products Regulatory Agency recently approved a phase 1 study that will test an inhaled mRNA-based drug as a treatment and prophylaxis of respiratory viral infections, according to a press release.